Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3367

Actual shortage: 219 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 3138 (93%)

Discontinuation Reports

365

To be discontinued: 24 (7%)
Discontinued: 341 (93%)
Reversed: 0 (0%)

Late reports

144 (4%)

Overdue reports

68 (28%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-SIMVASTATIN 40MG TABLET Resolved 2023-09-07 2024-03-01 203834
APO-SIMVASTATIN 40MG TABLET Resolved 2023-10-06 2023-12-01 206576
APO-SIMVASTATIN 10MG TABLET Resolved 2023-11-10 2023-11-24 209939
APO-SIMVASTATIN 20MG TABLET Resolved 2019-04-04 2019-04-15 80545
APO-SITAGLIPTIN MALATE 25MG TABLET Resolved 2024-04-12 2024-05-31 224977
APO-SITAGLIPTIN MALATE 50MG TABLET Resolved 2024-04-12 2024-05-31 224996
APO-SITAGLIPTIN MALATE 100MG TABLET Resolved 2024-04-26 2024-06-21 226345
APO-SITAGLIPTIN MALATE 100MG TABLET Resolved 2024-05-03 2024-06-21 227016
APO-SITAGLIPTIN MALATE 25MG TABLET Resolved 2023-02-09 2023-04-06 184112
APO-SITAGLIPTIN MALATE 100MG TABLET Resolved 2023-03-30 2023-04-14 188411
APO-SITAGLIPTIN MALATE 50MG TABLET Resolved 2023-03-30 2023-05-19 188415
APO-SITAGLIPTIN MALATE 25MG TABLET Resolved 2024-05-10 2024-05-31 227717
APO-SITAGLIPTIN MALATE 25MG TABLET Resolved 2024-08-29 2024-10-04 236246
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 850MG 50MG TABLET Resolved 2024-07-05 2024-09-27 232324
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 500MG 50MG TABLET Resolved 2024-07-05 2024-08-09 232328
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 1000MG 50MG TABLET Actual shortage 2025-03-13 2025-04-17 252564
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 1000MG 50MG TABLET Resolved 2022-12-16 2023-02-02 178778
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 1000MG 50MG TABLET Resolved 2022-12-16 2023-02-02 178781
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 500MG 50MG TABLET Resolved 2023-01-06 2023-07-27 180124
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE 500MG 50MG TABLET Resolved 2023-03-02 2023-07-27 185948
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-FENTANYL MATRIX 100MCG PATCH Discontinued 2018-02-23 2018-12-28 40741
APO-FENTANYL MATRIX 25MCG PATCH Discontinued 2018-09-07 2018-09-15 60489
APO-FENTANYL MATRIX Discontinued 2018-09-07 2018-09-15 60494
APO-FENTANYL MATRIX 75MCG PATCH Discontinued 2018-09-07 2018-09-15 60497
APO-FLUNISOLIDE NASAL SPRAY 0.25MG METERED-DOSE PUMP Discontinued 2018-02-26 2018-02-26 40965
APO-FLUVOXAMINE TABLETS 100MG TABLET Discontinued 2017-03-30 2018-02-05 4713
APO-FLUVOXAMINE TABLETS 50MG TABLET Discontinued 2017-03-30 2018-02-05 4716
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2019-01-02 2019-01-02 70815
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2018-02-26 2018-02-26 40997
APO-GEMFIBROZIL 600MG TABLET Discontinued 2017-03-31 2017-03-31 4927
APO-GEMFIBROZIL CAP 300MG USP 300MG CAPSULE Discontinued 2017-03-31 2018-12-07 4920
APO-GEMFIBROZIL CAP 300MG USP Discontinued 2019-06-12 2019-06-12 86557
APO-GLICLAZIDE 80MG TABLET Discontinued 2018-09-07 2018-09-15 60512
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94452
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94446
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94449
APO-HALOPERIDOL TAB 2MG 2MG TABLET Discontinued 2017-03-13 2017-03-13 1084
APO-HALOPERIDOL TAB 5MG 5MG TABLET Discontinued 2017-03-13 2017-03-13 1087
APO-HYDROMORPHONE CR 18MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110965
APO-HYDROMORPHONE CR 12MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110962